Preventional effect for a virus disease by the beta-glucan

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020529

Enrollment

Registered

2016-01-20

Start date

2016-01-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza and the norovirus-related gastroenteritis

Interventions

A participant ingest beta-glucan (50mg x 2) per day via naso-gastric tube, gastric fistula or intestinal fistula for 6 months. No treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient receiving forcible nutrition via naso-gastric tube, gastric fistula or intestinal fistula at long-term medical treatment type hospital.

Exclusion criteria

Exclusion criteria: A patien whose conditon is unstable.

Design outcomes

Primary

Measure	Time frame
Having onset or not influenza and the norovirus-related gastroenteritis	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026